blablah

blablah
Send Message
View as an RSS Feed
  • All eyes on Yellen's congressional testimony  [View news story]
    C'mon Yellen, you can do it, adding back trillions of dollars back to world markets with a few words coming out of your mouth..
    Feb 10, 2016. 05:54 AM | 5 Likes Like |Link to Comment
  • Nick's Picks 2016: Old Tech, Financials, Industrials, And Health Foods  [View article]
    $BX results in K-1in IRA ,right?
    Feb 9, 2016. 07:48 PM | Likes Like |Link to Comment
  • FDA grants Priority Review for AbbVie's venetoclax NDA  [View news story]
    Venetoclax is showing across the board activity in bcl-2 involved malignancies and even in elderly AML..
    Feb 9, 2016. 07:47 PM | Likes Like |Link to Comment
  • AbbVie Stands For Abnormally Vulnerable  [View article]
    Acalibrutinib will replace Ibrutinib if the safety profile holds up well, no question. In real life experience in older patients, I have seen significant bleeding and cardiovascular issues from Ibrutinib, much more than the trials suggest
    Feb 9, 2016. 07:43 PM | Likes Like |Link to Comment
  • AbbVie Stands For Abnormally Vulnerable  [View article]
    Acalibrutinib will replace Ibrutinib if the safety profile holds up well, no question. In real life experience in older patients, I have seen significant bleeding and cardiovascular issues from Ibrutinib..
    Feb 9, 2016. 07:41 PM | Likes Like |Link to Comment
  • Adaptimmune's enhanced T cells a Breakthrough Therapy for soft tissue cancer  [View news story]
    Her2 neu pts already have a lot of treatment options, approval criteria will be much more stringent, See what happened to Neratinib for Her 2 positive breast Ca (PUMA biotech..)
    Feb 9, 2016. 01:46 PM | 2 Likes Like |Link to Comment
  • Gilead gains on Q4 beat; raises dividend, sets $12B buyback  [View news story]
    Stock will keep drifting down until some splashy acquisition is made. Good time to make one as the biotech prices are down by 30-40%
    Feb 2, 2016. 04:21 PM | 10 Likes Like |Link to Comment
  • Gilead dragged down by AbbVie's V-Pak miss  [View news story]
    ABBV made big mistake with vpak and overpaying for Ibrutinib. AZN bought acalibrutinib by paying 4 billion and it will replace ibrutinib in the next 2-3 years
    Jan 29, 2016. 11:13 AM | Likes Like |Link to Comment
  • Gilead: There Is No Silver Lining To Zepatier, Time To Sell  [View article]
    They need to make a splashy acquisition to make Wall Street happy... Nothing else will move the share price higher ..
    Jan 29, 2016. 11:11 AM | 1 Like Like |Link to Comment
  • Lannett preliminary FQ2 results short of consensus; shares slump 17%  [View news story]
    Digoxin (that $LCI sells ) has increased mortality in Afib patients. The data came out yesterday or so and is adding to the drop
    Jan 28, 2016. 09:46 PM | Likes Like |Link to Comment
  • How Low Can Oil And The Markets Go?  [View article]
    Jason,
    Any insight about the recent bank earnings? Is C,BAC or JPM a buy at these levels?
    Jan 16, 2016. 09:56 AM | Likes Like |Link to Comment
  • How Low Can Oil And The Markets Go?  [View article]
    $ABBV paid 20 billion for pharmacyclics which I think is a big mistake. Ibrutinib will be soon upstaged by its modified competitor acalbrutinib which was bought up by $AZN..
    Jan 16, 2016. 09:46 AM | Likes Like |Link to Comment
  • Worst ten-day start ever  [View news story]
    Guess the bottom is almost in as it bounced off the august low levels, but if 1850 range does not hold next wee, it is time run to the hills
    Jan 15, 2016. 04:45 PM | Likes Like |Link to Comment
  • WSJ: AstraZeneca in talks to buy cancer drug developer Acerta for $5B  [View news story]
    Acalabrutinib has much less side effects than Ibrutinib . Abbvie paid 20 billion for it! AZN is playing smart
    Dec 11, 2015. 06:30 PM | Likes Like |Link to Comment
  • Will The Commodity And Energy Collapse Sink The Markets In 2016?  [View article]
    I was optimistic until last month for energy sector to slowly recover, but saudis crushed that possibility . I respect Tack/DoctoRx's opinion as they are seasoned investors. Stocks, bonds everything is expensive and overleveraged .Caution is definitely warranted here else the tide will be going out and you know what Warren said about it..
    Dec 10, 2015. 02:25 AM | Likes Like |Link to Comment
COMMENTS STATS
165 Comments
189 Likes